Cynvenio Biosystems Finds $25.5M More For Cancer Diagnostics

Westlake Village-based Cynvenio Biosystems said Wednesday that it has raised $25.5M in a Series B funding round. The developer of life sciences equipment, used to profile cancer cells circulating in whole blood, came from Livzon Pharmaceutical Group, along with Greenwoods Private Equity Funds and Syno Capital. Cynvenio is led by Andre de Fusco. Cynvenio said the deal includes an agreement o set up a Chinese joint venture with Livzon Pharmaceutical Group. More information »